XML 20 R8.htm IDEA: XBRL DOCUMENT v3.24.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES          
Net income (loss) $ (1,663) $ (2,380) $ (6,455) $ 49,947  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:          
Depreciation and amortization, including amortization of capitalized loan costs     53,314 51,295  
(Gain) loss on sale of real estate and other investments     577 (60,159)  
Loss on litigation settlement 0 2,864 0 2,864 $ 1,000
Share-based compensation expense     1,481 2,109  
Other, net     1,916 391  
Changes in other assets and liabilities:          
Other assets     1,748 2,866  
Accounts payable and accrued expenses     (5,317) (3,752)  
Net cash provided by operating activities     47,264 45,561  
CASH FLOWS FROM INVESTING ACTIVITIES          
Increase in mortgages and real estate related notes receivable     (13,147) 0  
Net proceeds from sale of real estate and other investments     18,251 141,587  
Proceeds from insurance     1,949 717  
Payments for improvements of real estate investments     (35,586) (25,072)  
Other investing activities     117 14  
Net cash provided by (used by) investing activities     (28,416) 117,246  
CASH FLOWS FROM FINANCING ACTIVITIES          
Proceeds from mortgages payable     0 90,000  
Principal payments on mortgages payable     (3,125) (22,796)  
Proceeds from revolving lines of credit     58,556 62,279  
Principal payments on revolving lines of credit     (40,556) (156,790)  
Principal payments on notes payable     0 (100,000)  
Net proceeds from issuance of common shares     7,388 0  
Repurchase of common shares     (4,703) (6,718)  
Distributions paid to common shareholders     (22,090) (21,879)  
Distributions paid to preferred shareholders     (3,214) (3,214)  
Distributions paid to Series D preferred unitholders     (320) (320)  
Distributions paid to noncontrolling interests – Operating Partnership and Series E preferred units     (4,596) (4,809)  
Other financing activities     (45) (140)  
Net cash used by financing activities     (12,705) (164,387)  
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH     6,143 (1,580)  
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT BEGINNING OF PERIOD     9,269 11,891 11,891
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF PERIOD 15,412 10,311 15,412 10,311 9,269
SUPPLEMENTARY SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES          
Accrued capital expenditures     4,915 4,638  
Operating partnership units converted to common shares     (1,367) (1,021)  
Distributions declared but not paid to common shareholders 11,907 11,608 11,907 11,608  
Series E preferred units converted to common shares     (1,220) (2,120)  
Retirement of shares withheld for taxes     121 179  
Loss on litigation settlement 0 2,864 0 2,864 1,000
Involuntary conversion of assets     (900) (1,060)  
Non-cash interest income     336 0  
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
Cash paid for interest     16,762 11,867  
Cash and cash equivalents 14,328 9,745 14,328 9,745 8,630
Restricted cash 1,084 566 1,084 566 639
Total cash, cash equivalents and restricted cash $ 15,412 $ 10,311 $ 15,412 $ 10,311 $ 9,269